Medicine and Dentistry
Absorptiometry
9%
Alendronic Acid
41%
Androgen
10%
Biochemical Marker
17%
Body Mass Index
14%
Bone Densitometry
11%
Bone Density
69%
Bone Mass
39%
Bone Turnover
30%
Case-Control Study
12%
Chorionic Gonadotropin
10%
Cohort Analysis
28%
Contraceptive Agent
11%
Cross Sectional Study
13%
Diethylstilbestrol
13%
Disease
9%
Dual-Energy X-Ray Absorptiometry
12%
Female Genital Tract Cancer
10%
Genital Injury
10%
Gestagen
19%
Glycon
28%
Hip
14%
Hormone Substitution
14%
Hormone Therapy
12%
Hyperandrogenism
18%
Insulin Resistance
14%
Lumbar Spine
15%
Maturity Onset Diabetes of the Young
15%
Mifepristone
10%
Misoprostol
10%
Obstetrics
14%
Oral Contraceptive
11%
Oral Contraceptive Agent
12%
Osteocalcin
16%
Osteolysis
47%
Osteoporosis
14%
Placebo
52%
Polycystic Ovary Syndrome
100%
Postmenopause
45%
Postmenopause Osteoporosis
20%
Premenopause
10%
Prevalence
31%
Primary Ovarian Insufficiency
10%
Quality of Life
12%
Randomized Controlled Trial
14%
Rape
9%
Symptom
28%
Systematic Review
16%
Uterine Artery Embolization
27%
Uterine Fibroid
19%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
5%
Alendronic Acid
43%
Alkaline Phosphatase
9%
Antiandrogen
5%
Biochemical Marker
30%
Bisphosphonic Acid Derivative
6%
Bleeding
7%
Cannabis
5%
Chorionic Gonadotropin
10%
Clinical Trial
11%
Cohort Study
11%
Collagen Type 1
8%
Creatinine
6%
Cross-Sectional Study
11%
Diethylstilbestrol
26%
Drug Utilization
5%
Endocrine Therapy
7%
Enzyme-Linked Immunosorbent Assay
6%
Escitalopram
5%
Fragility Fracture
6%
Gender Dysphoria
5%
Hydrocortisone
10%
Ibandronic Acid
11%
Levonorgestrel
6%
Major Depression
6%
Metformin
16%
Mifepristone
10%
Misoprostol
10%
Non Insulin Dependent Diabetes Mellitus
5%
Obesity
6%
Opiate
13%
Oral Contraceptive
5%
Oral Contraceptive Agent
5%
Osteocalcin
24%
Ovary Polycystic Disease
37%
Pioglitazone
5%
Placebo
69%
Placebo-Controlled Study
6%
Postmenopause Osteoporosis
30%
Premature Ovarian Failure
5%
Prevalence
13%
Progestin
16%
Randomized Controlled Trial
6%
Replacement Therapy
15%
Salcatonin
13%
Spironolactone
8%
Telopeptide
9%
Tolerability
5%
Tranexamic Acid
5%
Transdermal
8%
Biochemistry, Genetics and Molecular Biology
Blood Level
8%
Blood Pressure
11%
Body Composition
10%
Body Mass
14%
Body Size
5%
Bone Density
60%
Bone Mass
46%
Bone Metabolism
5%
Bone Turnover
26%
Bovine Somatotropin
5%
C-Peptide
5%
Cohort Study
20%
Comorbidity
5%
Corticotropin-Releasing Hormone
5%
Cortisol
5%
Cross Sectional Study
9%
Fat Mass
15%
Glucose Test
10%
Glucose Tolerance Test
10%
Growth Hormone
5%
Impaired Glucose Tolerance
7%
Insulin Resistance
12%
Insulin-Like Growth Factor 1
5%
Insulin-Like Growth Factor 2
5%
Interleukin 6
5%
Lipid Profile
5%
Menstruation
5%
Muscle Strength
6%
Osteocalcin
30%
Osteolysis
40%
Postmenopause
41%
Premenopause
13%
Prevalence
22%
Prolactin
10%
Randomized Controlled Trial
10%
Screening
5%
Triglyceride
7%
Type I Collagen
5%
X Ray
6%
